Unique patent pending, fully enclosed catheter eliminates airborne or touch contamination of the catheter, based on design.
The M29™ is the first and only FDA cleared Midterm™ (up to 29 days dwell time) catheter system. The M/29 bridges the midterm™ gap and offers a superior choice to both short peripheral catheters and traditional midline catheters
Fewer needle sticks, a simple insertion procedure and a soft flexible catheter means better patient care. Patients will no longer need to face the frequent insertion pain, bruising, and the risk of
complications such as phlebitis
complications such as phlebitis